RECRUITING

Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

Description

The goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body composition outcomes of moderately preterm infants born between 27 and 31 weeks of gestation.

Conditions

Study Overview

Study Details

Study overview

The goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body composition outcomes of moderately preterm infants born between 27 and 31 weeks of gestation.

A Multicenter Randomized Clinical Trial Comparing Two Human Milk Volumes to Optimize Growth and Gut Health in Infants Born Very Preterm

Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

Condition
Prematurity
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35294

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Gestational age between 27 0/7 and 31 6/7 weeks
  • * Birthweight of 1500 grams or less
  • * Human milk feeding during the first 14 days after birth
  • * Full enteral feeding (120mL/kg/day or more) within the first 14 days after birth
  • * Necrotizing enterocolitis stage 2 or greater
  • * Spontaneous intestinal perforation
  • * Major congenital/chromosomal anomalies
  • * Terminal illness requiring limited or withheld support
  • * Intention to restrict fluid intake after the first 14 postnatal days due to the presence of a symptomatic patent ductus arteriosus (PDA)
  • * Any formula feeding within the first 14 days after birth

Ages Eligible for Study

6 Hours to 4 Days

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Alabama at Birmingham,

Ariel A. Salas, MD, MSPH, PRINCIPAL_INVESTIGATOR, UAB Hospital

Study Record Dates

2030-05